Response Adaptive Salvage Treatment with Carfilzomib-ThalidomideDexamethasone for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line BortezomibBased Induction Therapy - Final Analysis from the Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial
BLOOD(2021)
摘要
BACKGROUND
更多查看译文
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要